Mayank Mamtani

Stock Analyst at B. Riley Securities

(1.52)
# 1816
Out of 5,441 analysts
179
Total ratings
Success rate
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
ALT Altimmune
Maintains: Buy
20 18
3.38 432.54% 10 Aug 13, 2025
NKTR Nektar Therapeutics
Maintains: Strong Buy
60 85
22.48 278.11% 2 Jul 8, 2025
MNOV MediciNova
Maintains: Buy
6 5
1.34 273.13% 2 Jun 16, 2025
MGNX Macrogenics
Maintains: Neutral
5 3
1.47 104.08% 2 May 20, 2025
MDGL Madrigal Pharmaceuti...
Reiterates: Strong Buy
422 460
349.43 31.64% 12 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
69 65
33.76 92.54% 2 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 2
n/a n/a 6 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
11 20
7.33 172.85% 3 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
1 200% 2 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38 35
13.91 151.62% 2 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 38
17.2 120.93% 7 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 96
38.19 151.37% 2 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
1 2
0.85 76.47% 3 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
23 26
8.04 223.38% 19 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 4 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
16.6 98.8% 1 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 34
26.4 28.79% 13 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
122 92
33.2 177.11% 3 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 33
32.48 0.06% 7 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
4.26 -6.1% 3 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 4
1.54 127.27% 5 Nov 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
140
15.79 786.64% 1 Oct 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 19
19 0% 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
210 90
1.43 6193.71% 5 Apr 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
160
4.27 3647.07% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2 1
1.02 -1.96% 4 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 5
1.46 242.47% 3 Aug 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
58 44
2.25 1855.56% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 90
1.92 4587.5% 4 Jul 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 7
2.4 191.67% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
600 450
n/a n/a 1 Mar 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
850 500
n/a n/a 1 Mar 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1
n/a n/a 6 Mar 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
2.38 236.13% 2 Mar 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23040 15360
n/a n/a 2 Mar 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9750 4500
1.75 257042.86% 3 Jan 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5000 2700
1.78 151585.39% 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
n/a n/a 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
138 77
11.39 576.03% 2 Jan 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
96
3.37 2748.66% 2 Jul 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1980 1440
1.45 99210.34% 3 May 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
3.85 3.9% 2 Apr 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
70 30
0.82 3558.54% 2 Apr 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
47 39
95.13 -59% 2 Mar 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 34
3.78 799.47% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 20
n/a n/a 1 Dec 10, 2019